| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.40B | 1.29B | 1.11B | 905.18M | 698.99M | 502.03M |
| Gross Profit | 218.91M | 178.80M | 131.02M | 122.19M | 104.35M | 81.90M |
| EBITDA | 46.23M | 21.33M | -20.48M | -29.01M | -23.25M | 2.73M |
| Net Income | 15.46M | -9.63M | -44.69M | -44.67M | -35.53M | -5.84M |
Balance Sheet | ||||||
| Total Assets | 880.17M | 806.85M | 782.95M | 671.63M | 562.58M | 498.25M |
| Cash, Cash Equivalents and Short-Term Investments | 348.53M | 307.38M | 277.17M | 222.41M | 213.41M | 229.74M |
| Total Debt | 114.54M | 128.89M | 128.93M | 69.46M | 0.00 | 0.00 |
| Total Liabilities | 511.61M | 483.58M | 479.23M | 366.33M | 230.38M | 158.31M |
| Stockholders Equity | 368.56M | 323.27M | 303.72M | 305.30M | 332.20M | 339.94M |
Cash Flow | ||||||
| Free Cash Flow | 71.86M | 38.57M | 358.00K | -25.09M | -4.90M | 14.09M |
| Operating Cash Flow | 83.93M | 48.29M | 18.64M | -8.00M | 7.46M | 21.54M |
| Investing Cash Flow | -35.30M | -13.46M | 7.64M | -67.52M | -51.91M | -76.75M |
| Financing Cash Flow | -19.46M | -3.96M | 59.13M | 60.74M | -1.13M | 170.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $474.48M | 13.22 | 13.12% | 4.20% | 13.47% | 26.15% | |
72 Outperform | $729.91M | 14.77 | 16.95% | 6.64% | -1.73% | -18.36% | |
69 Neutral | $1.63B | 106.00 | 4.49% | ― | 12.50% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $961.88M | 16.85 | 5.86% | 2.94% | 1.69% | -52.43% | |
64 Neutral | $691.42M | 16.12 | 10.46% | 1.31% | 4.44% | 22.40% | |
63 Neutral | $798.31M | 8.55 | 25.65% | ― | 34.48% | ― |
On November 4, 2025, Trupanion entered into a new credit agreement with PNC Bank, securing a $120 million credit facility to enhance financial flexibility and support long-term growth. This facility, which replaces a prior agreement, offers a lower interest rate, allowing Trupanion to allocate capital towards strategic initiatives. The announcement coincides with Trupanion’s strong third-quarter financial results, including a 12% revenue increase to $366.9 million and a significant rise in net income to $5.9 million. The company continues to demonstrate robust financial performance, positioning itself for sustainable growth and expanded access to pet medical care.
On October 29, 2025, Trupanion, Inc. announced the appointment of Bradley S. Powell to its Board of Directors. Powell, who previously served as CFO at Expeditors International of Washington, brings extensive financial and strategic expertise to Trupanion. His appointment is expected to bolster Trupanion’s growth strategy and enhance shareholder value, as the company continues to scale its operations in the pet insurance industry.